Please see below for a list of search results.
The HTA has a responsibility to make its information available in accordance with the FOI Act.
In order to increase the accessibility of this site, we have provided a number of Access keys. These are keyboard shortcuts providing an alternative form of navigation.
As a regulator, transparency is not only an aspiration and value, but a statutory duty under the Human Tissue Act. It is also a priority for the Department of Health and Government more generally.
The Human Tissue Authority (HTA) is the national independent regulator for organisations that remove, store and use tissue for research, medical treatment, post-mortem examination, teaching and display in public. We also give approval for organ and bone marrow donations from living people.
The Human Tissue Authority is committed to promoting equality and diversity, both as an employer and in the carrying out of its public functions to monitor and promote good practice in the sectors that it regulates.
This page details the HTA's finance and administration.
The Human Tissue Authority receives funding from two sources: (82%) from licence fees with the balance (18%) coming from our sponsors the Department of Health (DH).
The activities funded by licence fee income range from...
The HTA routinely responds to consultations about issues which fall inside our regulatory remit.
The HTA's Business Plans and Strategies are available to view as PDFs and web pages. Each Business Plan sets out our priorities and objectives for the business year, and each Strategy provides a longer term view of organisation priorities and activities, centred around our core themes of...